Providing guidance about Regulatory Affairs and Trade changes in the Pharma and Medical Devices industries
Join our online conference on the 10th of February, 2021, 3:00 to 4:00 p.m. (CET) to be up to date about the impact of the new regulations in Pharma and Medical Devices in the UK.
About the conference:
The pharmaceutical sector is the third largest industry in the UK, and with Brexit happening the UK is living in a time of great change, with challenges and risks ahead, but also potential opportunities that can have a positive impact on the pharma industry.
Lidia Cánovas, General Manager, Regulatory Affairs at Asphalion will clarify the main regulatory changes in 2021 in Pharma and Medtech due to Brexit. She will focus on:
After that, Linda Magee, Health Innovation and NHS Specialist in the Healthcare, Life Sciences and Bio-Economy Sector in the UK Government’s Department for International Trade (DIT) will discuss the following topics:
Jessica Griffiths, Senior Trade & Investment Advisor at DIT will be moderating the session.
More information and registration: https://forms.gle/S5HPNhrNwcfS9qzr9